Anti-SARS-COV-2 nsp8 antibody [EPR24854-42] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal R1AB antibody. Carrier free. Suitable for WB, I-ELISA, IHC-P and reacts with SARS-CoV-2 samples. Cited in 1 publication.
View Alternative Names
1a-1b, rep, Replicase polyprotein 1ab, pp1ab, ORF1ab polyprotein
- IHC-P
Collaborator84138****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SARS-COV-2 nsp8 antibody [EPR24854-42] - BSA and Azide free (AB283955)
This data was developed using ab283954, the same antibody clone in a different buffer formulation. ab283954 staining SARS-CoV-2 nsp8 in Human Lung (SARS-CoV-2 RNA+) tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde, antigen retrieval was by heat mediation in a Citrate Buffer (pH 6). Samples were incubated with primary antibody (1/1500) for 45 minutes at 24°C. A Rabbit HRP-conjugated secondary antibody was used.
This image is courtesy of an Abreview submitted by Dr, Aron Emmi
- I-ELISA
Supplier Data
Indirect ELISA - Anti-SARS-COV-2 nsp8 antibody [EPR24854-42] - BSA and Azide free (AB283955)
Indirect ELISA showing primary antibody ab283954 binding to recombinant SARS-CoV-2 NSP8 his-tag protein. Plates were coated with recombinant SARS-CoV-2 NSP8 his-tag protein and recombinant SARS-CoV-2 NSP10/16 his-tag protein at 1000 ng/ml. Binding of ab283954 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution).
Binding was detected using pre-adsorbed secondary antibody, goat anti-rabbit IgG H&L (HRP, ab97080) at 1/2000 dilution.
- WB
Supplier Data
Western blot - Anti-SARS-COV-2 nsp8 antibody [EPR24854-42] - BSA and Azide free (AB283955)
Lanes 1 - 2 : Red – loading control ab18184 (Mouse monoclonal [HIS.H8] to 6X His tag®) observed at 24 kDa.
Lanes 3 - 4 : Green – ab283954 observed at 24 kDa
ab283954 was shown to bind specifically to SARS-CoV-2 NSP8 protein in Western blot. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
Blocking buffer : 3% milk in TBS-0.1% Tween® 20 (TBS-T)
Lanes 1 - 2:
Western blot - Anti-SARS-COV-2 nsp8 antibody [EPR24854-42] (<a href='/en-us/products/primary-antibodies/sars-cov-2-nsp8-antibody-epr24854-42-ab283954'>ab283954</a>)
Lanes 3 - 4:
Western blot - Anti-SARS-COV-2 nsp8 antibody [EPR24854-42] (<a href='/en-us/products/primary-antibodies/sars-cov-2-nsp8-antibody-epr24854-42-ab283954'>ab283954</a>) at 1/1000 dilution
Lanes 1 and 3:
Recombinant SARS-CoV2 NSP8 protein (His tagged) at 0.5 µg
Lanes 2 and 4:
Recombinant SARS-CoV2 NSP8 protein (His tagged) at 0.2 µg
Secondary
Lanes 1 - 2:
Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/20000 dilution
Lanes 3 - 4:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Observed band size: 24 kDa
false
Reactivity data
Product details
ab283955 is the carrier-free version of ab283954.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Nsp8 cooperates with non-structural protein 12 (nsp12) to form the RNA-dependent RNA polymerase (RdRp) complex. This complex is essential for the replication and transcription of the viral genome. Nsp8 nsp12 and nsp7 come together as a multi-protein complex enhancing the activity of the RdRp. Nsp8 has been shown to stabilize the structure and function of the replication machinery providing the necessary support for the synthesis of the viral RNA strand.
Pathways
Nsp8 plays an important role in the viral replication and transcription pathways. The polymerase activity driven by the complex of nsp8 nsp12 and nsp7 operates through the replication-transcription complex important for efficient viral propagation within the host. This process not only involves the formation of viral RNA genomes but also subgenomic RNAs which are required for viral protein translation. The interaction between these non-structural proteins ensures that the virus maintains a high level of infectious presence in its host.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
BMC pulmonary medicine 24:477 PubMed39334020
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com